| Michelle Sue Rhodes-gloor, FNP-C | |
|
2355 N Wyatt Dr Ste 101, Tucson, AZ 85712-2120 | |
| (520) 616-4948 | |
| Not Available |
| Full Name | Michelle Sue Rhodes-gloor |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 2355 N Wyatt Dr Ste 101, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265042659 | NPI | - | NPPES |
| 080558 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 245646 (Arizona) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 245646 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marana Health Center Inc | 2365348091 | 83 |
News Archive
Clementia Pharmaceuticals, Inc. announced today the initiation of a Phase 2 extension study of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling genetic disease characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) and new abnormal bone formation.
Sanofi pasteur has announced that it is ready to supply a significant number of doses of H5N1 vaccine for the establishment of an international stockpile through a World Health Organization (WHO) partnership.
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
Mind Technologies, Inc., announced today that the Company will begin selling the Emotiv EEG headset in addition to the thought-controlled software applications the Company develops.
"The Tennessee Senate on Thursday approved a bill to allow state hospitals to pay a fee to avoid $659 million in TennCare cuts. Democratic Gov. Phil Bredesen had originally proposed cutting $201 million from the state's expanded Medicaid program to help balance the states [sic] budget. Those cuts would be averted through the hospital assessment" (4/29).
› Verified 6 days ago
| Entity Name | Marana Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447263405 PECOS PAC ID: 2365348091 Enrollment ID: O20031211000790 |
News Archive
Clementia Pharmaceuticals, Inc. announced today the initiation of a Phase 2 extension study of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling genetic disease characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) and new abnormal bone formation.
Sanofi pasteur has announced that it is ready to supply a significant number of doses of H5N1 vaccine for the establishment of an international stockpile through a World Health Organization (WHO) partnership.
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
Mind Technologies, Inc., announced today that the Company will begin selling the Emotiv EEG headset in addition to the thought-controlled software applications the Company develops.
"The Tennessee Senate on Thursday approved a bill to allow state hospitals to pay a fee to avoid $659 million in TennCare cuts. Democratic Gov. Phil Bredesen had originally proposed cutting $201 million from the state's expanded Medicaid program to help balance the states [sic] budget. Those cuts would be averted through the hospital assessment" (4/29).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Sue Rhodes-gloor, FNP-C Po Box 188, Marana, AZ 85653-0188 Ph: (520) 616-4948 | Michelle Sue Rhodes-gloor, FNP-C 2355 N Wyatt Dr Ste 101, Tucson, AZ 85712-2120 Ph: (520) 616-4948 |
News Archive
Clementia Pharmaceuticals, Inc. announced today the initiation of a Phase 2 extension study of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling genetic disease characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) and new abnormal bone formation.
Sanofi pasteur has announced that it is ready to supply a significant number of doses of H5N1 vaccine for the establishment of an international stockpile through a World Health Organization (WHO) partnership.
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
Mind Technologies, Inc., announced today that the Company will begin selling the Emotiv EEG headset in addition to the thought-controlled software applications the Company develops.
"The Tennessee Senate on Thursday approved a bill to allow state hospitals to pay a fee to avoid $659 million in TennCare cuts. Democratic Gov. Phil Bredesen had originally proposed cutting $201 million from the state's expanded Medicaid program to help balance the states [sic] budget. Those cuts would be averted through the hospital assessment" (4/29).
› Verified 6 days ago